Flavonoid-rich Mediterranean diet for people with multiple sclerosis
A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis
This trial will test whether following a flavonoid-rich Mediterranean diet can change disease measures and symptoms in adults with multiple sclerosis who have EDSS scores of 0–6.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 30 Years to 65 Years |
| Sex | All |
| Sponsor | Hasselt University Academic / other |
| Locations | 1 site (Diepenbeek, Limburg) |
| Trial ID | NCT07033975 on ClinicalTrials.gov |
What this trial studies
This interventional study asks participants with multiple sclerosis to follow a flavonoid-enriched Mediterranean dietary pattern to see how nutrition affects disease-related parameters. The protocol focuses on a healthier, plant-forward diet high in flavonoids rather than a drug or device intervention. Outcomes will include clinical measures related to MS and likely biomarkers or symptom measures to capture any change during the intervention. The trial enrolls ambulatory participants (EDSS 0–6) without diagnosed digestive pathology and is conducted at Hasselt University in Diepenbeek, Belgium.
Who should consider this trial
Good fit: Ideal candidates are adults with a diagnosis of multiple sclerosis who are ambulatory with EDSS between 0 and 6, have no diagnosed digestive disease, and can attend visits at the Hasselt University site.
Not a fit: People with more advanced disability (EDSS >6), those with diagnosed digestive pathologies, or those unable to follow the dietary program are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the diet could offer a low-risk way to reduce inflammation or symptoms and slow disease-related changes in people with MS.
How similar studies have performed: Observational studies have linked Mediterranean-style diets with better outcomes in MS, but randomized and flavonoid-specific interventional evidence remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Expanded Disability Status Scale (EDSS): 0-6 Exclusion Criteria: * Diagnosed digestive pathology
Where this trial is running
Diepenbeek, Limburg
- Hasselt University — Diepenbeek, Limburg, Belgium (Recruiting)
Study contacts
- Study coordinator: Jerome JA Hendriks, Professor
- Email: jerome.hendriks@uhasselt.be
- Phone: +3211269207
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.